Australian Shares is the world's biggest free online database of information on Australian resource companies.

Time to Update your company profile
Australian Shares



The data on Australian is intended as a guide only and is compiled from information in the public domain. Data on this website should not be used to make an investment or trading decision.


BPH (previously BioPharmica Limited) was formed in 2004 and is a listed company on the Australian Securities Exchange under code BPH. The company is commercialising a portfolio of Australian biomedical technologies emerging from research by leading Universities, Medical Institutes and Hospitals across Australia. Targeting large global markets BPH provides product development and commercial direction, whilst the institutional partner provides the majority of the infrastructure and research expertise.

Technologies on the way to commercialisation include: Diagnostic Array Systems, BacTrak a faster and more effective method of detecting infectious disease; Cortical Dynamics Brain Anaesthesia Response (BAR) Monitor - a device that measures a patient’s brain electrical activity (EEG) to indicate the response to drugs administered during surgery; HLS5 Tumour Suppress Gene a molecular marker for early and accurate cancer detection; and microtubule drugs that target the tumour vasculature.

Molecular Discovery Systems (MDSystems) is a 20% owned subsidiary of BPH that was launched in 2006 for drug discovery and the validation of biomarkers for disease, therapy and diagnostics. The company utilizes the InCell Analyser 1000 for high throughout imaging and analysis, providing services for researchers worldwide.

BPH has an interest in a SERS Nanoprobe an optical fibre to be used in biosensors for diagnostic testing and drug development.

BPH Energy also has investment with Advent Energy Limited which is an unlisted oil and gas exploration company. Advent holds a strong portfolio of exploration and near-term production assets throughout Australia. Advent’s cornerstone project lies off the coast of NSW in Petroleum Exploration Permit 11 (PEP11), and has been estimated to comprise up to 13.2 Tcf (P50 or ‘best estimate’ level) prospective recoverable gas. The resources are adjacent to the major population region of Sydney and excellent port and power generation infrastructure.

Mine For

oil, gas

Location of operation(s)

New South Wales

Australian Basins

Offshore Sydney


14 View Street
NORTH PERTH, WA, Australia


+61 8 9328 8366



Last Updated



The data on Australian is intended as a guide only and is provided purely as an indication of what information can be found through official announcements. Data on this website should not be used to make an investment or trading decision. All information should be carefully cross-checked against official sources for accuracy. The publisher (Intaanetto Pty Ltd) will not be held liable for any loss arising from the use of this website.